MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 30 filers reported holding MILESTONE PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,380,000 | +18.1% | 2,000,000 | -20.9% | 0.88% | +14.4% |
| Q2 2022 | $15,560,000 | -4.2% | 2,530,003 | 0.0% | 0.77% | -10.6% |
| Q1 2022 | $16,243,000 | -2.0% | 2,530,003 | -0.0% | 0.86% | +9.2% |
| Q4 2021 | $16,575,000 | +14.7% | 2,530,585 | 0.0% | 0.78% | +5.1% |
| Q3 2021 | $14,450,000 | +3.8% | 2,530,585 | 0.0% | 0.75% | +21.1% |
| Q2 2021 | $13,918,000 | -5.0% | 2,530,585 | 0.0% | 0.62% | +2.0% |
| Q1 2021 | $14,652,000 | -13.6% | 2,530,585 | 0.0% | 0.60% | -16.8% |
| Q4 2020 | $16,955,000 | +11.3% | 2,530,585 | +21.6% | 0.73% | -3.8% |
| Q3 2020 | $15,230,000 | +93.6% | 2,080,585 | 0.0% | 0.76% | +48.8% |
| Q2 2020 | $7,865,000 | +105.5% | 2,080,585 | 0.0% | 0.51% | +99.2% |
| Q1 2020 | $3,828,000 | -90.2% | 2,080,585 | -14.5% | 0.26% | -89.8% |
| Q4 2019 | $38,976,000 | -21.9% | 2,434,470 | -9.0% | 2.51% | -70.6% |
| Q3 2019 | $49,879,000 | -31.3% | 2,674,470 | 0.0% | 8.54% | -16.0% |
| Q2 2019 | $72,612,000 | – | 2,674,470 | – | 10.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management III, LLC | 2,066,529 | $38,541,000 | 23.79% |
| Novo Holdings A/S | 2,674,470 | $49,879,000 | 8.54% |
| ACUTA CAPITAL PARTNERS, LLC | 369,500 | $6,891,000 | 4.97% |
| RTW INVESTMENTS, LP | 3,521,856 | $63,819,000 | 3.80% |
| Boxer Capital, LLC | 1,102,194 | $20,556,000 | 1.49% |
| Ghost Tree Capital, LLC | 235,000 | $4,383,000 | 1.12% |
| VHCP Management II, LLC | 148,560 | $2,771,000 | 1.06% |
| Tekla Capital Management LLC | 46,940 | $812,000 | 0.04% |
| Baker Brothers Advisors | 266,667 | $4,973,000 | 0.03% |
| Zimmer Partners, LP | 160,000 | $2,984,000 | 0.03% |